Mr Gijs Berkelmans
University Medical Center Utrecht, Utrecht (Netherlands (The))
Treatment decisions based on individual estimated lifetime benefit versus individual estimated 10-year absolute risk reduction: a cost-effectiveness analyses with PCSK9 inhibition.
Event: ESC Congress 2018
Topic: Epidemiology
Session: Best Posters in preventive cardiology
Dealing with missing patient characteristics in clinical practice when using cardiovascular prediction models.
Event: ESC Congress 2018
Topic: Cardiovascular Risk Assessment
Session: Preventive cardiology
Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.
Event: ESC Congress 2016
Topic: Epidemiology, lipids
Session: Lipoproteins and real life: what the randomized clinical trials do not show us
ESC 365 is supported by
